Faculty Disclosures
| Phillip Banks, MS |
Mr. Banks has received personal compensation for serving as an employee of Lexicon Pharmaceuticals. Mr. Banks has stock in Lexicon Pharmaceuticals. |
| Stefanie Geisler, MD |
The institution of Dr. Geisler has received research support from NIH. The institution of Dr. Geisler has received research support from Foundation for Peripheral Neuropathy. Dr. Geisler has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Geisler has received publishing royalties from a publication relating to health care. |
| Zuhuan Cai |
Miss Cai has received personal compensation for serving as an employee of Chengdu Kanghong Pharmaceutical Garoup Co.,Ltd.. |
| Manon Girard |
Ms. Girard has nothing to disclose. |
| Joseph G. Wettstein, PhD |
Dr. Wettstein has received personal compensation for serving as an employee of Noema Pharma. |
| Nino Goguadze, MD, PhD |
Dr. Goguadze has nothing to disclose. |
| Ke Mu |
Dr. Mu has received personal compensation for serving as an employee of Chengdu Kanghong Pharmaceutical Group Co., Ltd.. |
| Volker A. Knappertz, MD |
Dr. Knappertz has received personal compensation for serving as an employee of Noema Pharmaceuticals . Dr. Knappertz has received intellectual property interests from a discovery or technology relating to health care. |
| Tsung-Ping Su, PhD |
The institution of Dr. Su has received research support from Intranural Research Program - NIH. |
| Barbara P. Karp, MD, FAAN |
Dr. Karp has nothing to disclose. |
| Phillip Pierce, MD |
Dr. Pierce has received personal compensation for serving as an employee of Lexicon Pharmaceuticals. Dr. Pierce has or had stock in Johnson & Johnson.Dr. Pierce has or had stock in Lexicon . |
| Nathaniel M. Schuster, MD |
Dr. Schuster has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Schedule 1 Therapeutics. Dr. Schuster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Averitas. Dr. Schuster has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lohocla Research Corporation. Dr. Schuster has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Vertex. Dr. Schuster has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Schuster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome. Dr. Schuster has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rapport Therapeutics. Dr. Schuster has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Schuster has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Averitas. Dr. Schuster has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pain Medicine Journal. Dr. Schuster has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum. Dr. Schuster has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Various Law Firms and the State of California. The institution of Dr. Schuster has received research support from Migraine Research Foundation. The institution of Dr. Schuster has received research support from UCSD Academic Senate. The institution of Dr. Schuster has received research support from NINDS 1 R01 AT012048-01A1. The institution of Dr. Schuster has received research support from NCCIH 5R00AT009466-04. The institution of Dr. Schuster has received research support from NCCIH U24 NS115714. The institution of Dr. Schuster has received research support from NIH/HEAL EN21-01. The institution of Dr. Schuster has received research support from ShiraTronics. |
| George M. Garibaldi, MD |
Dr. Garibaldi has nothing to disclose. |
| Hong Huang |
Dr. Huang has received personal compensation for serving as an employee of Chengdu Kanghong Pharmaceutical Group Co., Ltd. |
| Ting Liu, MD |
Ms. Liu has received personal compensation for serving as an employee of Chengdu Kanghong Pharmaceutical Group Co., Ltd. |
| Hsiang-En Wu, MD |
Dr. Wu has nothing to disclose. |
| Xiao Ke, PhD |
Dr. Ke has received personal compensation for serving as an employee of chengdu Kanghong Pharmaceutical Group Co., Ltd. |
| Suma Gopinathan, PhD |
Dr. Gopinathan has received personal compensation for serving as an employee of Lexicon Pharmaceuticals. Dr. Gopinathan has stock in Lexicon Pharmaceuticals. |
| yongguo Yu, PhD |
Mr. Yu has received personal compensation for serving as an employee of Chengdu Kanghong Pharmaceutical Group Co., Ltd. |
| Rosemarie Roeloffs, PhD |
Dr. Roeloffs has received personal compensation for serving as an employee of Noema Pharma. Dr. Roeloffs has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Noema Pharma. |
| Craig Granowitz, MD, PhD |
Dr. Granowitz has received personal compensation for serving as an employee of Lexicon Pharmaceuticals . Dr. Granowitz has received personal compensation in the range of $500,000-$999,999 for serving as an officer or member of the Board of Directors for Lexicon Pharmaceuticals . Dr. Granowitz has stock in Lexicon Pharmaceuticals . |
| Delphine Bernard |
No disclosure on file
|
| Yu Bai |
Dr. Bai has received personal compensation for serving as an employee of Chengdu Kanghong Pharma Co., Ltd.. |
| Marquette Hardin, PharmD |
Dr. Hardin has received personal compensation for serving as an employee of Lexicon Pharmaceuticals. Dr. Hardin has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Kappa Psi Pharmaceutical Fraternity. Dr. Hardin has stock in Lexicon Pharmaceuticals. |